Abstract
Psoriasis is one of the most common skin diseases. 30% of patients with psoriasis may develop psoriatic arthritis, which can lead to complex joint deformity and early disability. In this case, it is very important to have an interdisciplinary approach in the selective treatment of psoriasis and psoriatic arthritis using genetically engineered biological drugs. In our article, we present a world literature review on the use of genetically engineered biological drugs in psoriasis and psoriatic arthritis, describe a clinical case of psoriasis with psoriatic arthritis with effective basic treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
